Last updated on July 2019

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)

Brief description of study

Study ALD-103 will be a multi-site, global, prospective and retrospective data collection study that is designed to evaluate outcomes of allo-HSCT in male subjects with CALD 17 years of age.

Clinical Study Identifier: NCT02204904

Find a site near you

Start Over